This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Inscripta, Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Michael Clay: Innovator in Lysine Production
Introduction
Michael Clay is a prominent inventor based in Boulder, CO, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has focused on enhancing lysine production through innovative genetic modifications.
Latest Patents
Michael's latest patents include "Rationally-designed mutations to the thrA gene for enhanced lysine production" and "Genome-wide rationally-designed mutations leading to enhanced lysine production." These patents detail various mutations in the thrA gene that lead to improved lysine production, which is essential for supplements and nutraceuticals.
Career Highlights
Michael Clay is currently employed at Inscripta, Inc., a company that specializes in genome engineering. His work at Inscripta has positioned him at the forefront of biotechnological advancements, particularly in the area of amino acid production.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Richard Fox and Daniel Held. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Clay's work in enhancing lysine production through genetic engineering exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations continue to contribute to advancements in the field, showcasing the importance of research and development in creating effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile